Thoracic Aortic Aneurysm and Dissection: Review and Recommendations for Evaluation

Am J Forensic Med Pathol. 2023 Jun 1;44(2):69-76. doi: 10.1097/PAF.0000000000000819. Epub 2023 Mar 3.

Abstract

Aortic dissection and rupture (collectively termed "sudden aortic death") are commonly encountered by forensic pathologists, with an estimated incidence at autopsy between 0.6% and 7.7%. Despite this, there is no standard of practice for the evaluation of sudden aortic death at autopsy.Recent studies have shown 20% of patients with thoracic aortic aneurysm or dissection (TAAD) have an identifiable genetic syndrome, and 19% will have an affected first-degree relative. The past 2 decades have seen identification of new culprit genes and syndromes, which can have subtle or nonexistent external phenotypes. A high index of suspicion is warranted to identify possible hereditary TAAD (H-TAAD), allowing family members to obtain screening to avoid catastrophic vascular events. Forensic pathologists need broad knowledge of the spectrum of H-TAAD and awareness of the relative significance of hypertension, pregnancy, substance use, and microscopic changes of aortic architecture.This article reviews the common subtypes of H-TAAD, including Marfan syndrome, vascular Ehlers-Danlos, Loeys-Dietz, and familial thoracic aortic aneurysm and dissection. Recommendations for the evaluation of sudden aortic death at autopsy are presented, including (1) performance of a complete autopsy, (2) documentation of aortic circumference and valve morphology, (3) notifying family of the need for screening, and (4) preservation of a sample for potential genetic testing.

Publication types

  • Review

MeSH terms

  • Aorta
  • Aortic Aneurysm, Thoracic* / genetics
  • Aortic Dissection*
  • Humans
  • Marfan Syndrome* / diagnosis
  • Marfan Syndrome* / genetics

Substances

  • 1,3,4,6-tetra-O-acetyl-2-azido-2-deoxyglucopyranose